Will the new cancer vaccine survive RFK Jr’s America?
Summary
Host Asma Khalid and guest Tom Whipple discuss the promise and politics of mRNA technology, highlighting a new personalized cancer vaccine by Merck and Moderna. They trace the science’s history from Dr. Katalin Karikó’s early work to its Nobel-winning success against COVID-19. The episode also examines current U.S. policy debates, including RFK Jr.’s funding cuts and safety concerns, contrasting scientific optimism with political skepticism.
Topics discussed
Intro: mRNA history, Nobel Prize, and new cancer vaccine news
Explaining the personalized skin cancer vaccine breakthrough
How mRNA works and Dr. Kariko's decades of research
How the pandemic accelerated mRNA vaccine development
RFK Jr.'s funding cuts and claims on vaccine efficacy
Safety concerns and the FDA's approval of mRNA flu vaccine
Political implications and future of mRNA research funding
Outro: HHS statement and credits
Listen ad-free on Castria